Text Size
27 studies found for:    " March 17, 2010":" April 16, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" March 17, 2010":" April 16, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Adherence to HIV Therapy in Heroin Addicts
Conditions: HIV;   Substance Abuse;   HIV Infections
Interventions: Drug: Oral Naltrexone (ON);   Drug: Implantable Naltrexone (IN)
2 Active, not recruiting
Has Results 		Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: ATV/r + Truvada
3 Active, not recruiting
Has Results 		Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: Atripla
4 Completed
Has Results 		Study of Vitamin D and Effect on Heart Disease and Insulin Resistance
Conditions: HIV;   Vitamin D Deficiency;   HIV Infections
Intervention: Drug: Vitamin D
5 Completed Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners
Condition: HIV Infections
Interventions: Behavioral: Project POWER HIV Risk-reduction Intervention;   Behavioral: NC DOC Standard of Care for STIs
6 Completed Vitamin D Dose Finding Study
Conditions: HIV Infections;   AIDS
Intervention: Drug: Cholecalciferol (Vit D3)
7 Completed H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Biological: H1N1 vaccination
8 Recruiting Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
Condition: HIV Infections
Intervention: Procedure: Blood collection
9 Enrolling by invitation Mesalamine to Reduce T Cell Activation in HIV Infection
Conditions: HIV Infections;   Sexually Transmitted Diseases;   Immune System Diseases;   Lentivirus Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Mesalamine (5-aminosalicylic acid, Apriso);   Drug: Placebo
10 Unknown † Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
11 Completed GSK1349572 Relative Bioavailability Study
Condition: HIV Infections
Interventions: Drug: GSK1349572 formulation AP;   Drug: GSK1349572 formulation AW;   Drug: GSK1349572 formulation AX
12 Completed HIV Fat Redistribution and the Evaluation of Brown Fat
Condition: HIV Infections
Intervention:
13 Enrolling by invitation Test of an Intervention to Improve HIV Care
Condition: HIV Infection
Interventions: Behavioral: Patient Mentor Intervention;   Behavioral: HIV transmission risk reduction
14 Active, not recruiting Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: rAd35 Env A;   Biological: rAd5 Env A;   Biological: rAd5 Env B
15 Active, not recruiting PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
Condition: HIV Infections
Interventions: Drug: Atazanavir;   Drug: Ritonavir
16 Active, not recruiting Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: Ad26.ENVA.01 (rAd26);   Biological: Placebo Vaccine
17 Active, not recruiting
Has Results 		A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Reyataz + Norvir + Truvada;   Drug: Reyataz + Epzicom
18 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Conditions: Birth Defects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
19 Completed A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: GSK2248761;   Drug: GSK2248761 + Raltegravir
20 Recruiting Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of Pathophysiology
Conditions: HIV;   Cardiovascular Disease
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
† Indicates status has not been verified in more than two years